Turnover in Biological Technology

STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens

... treatments, STALLERGENES devotes 18% of its turnover to Research and Development, and in particular ... tablet form. In 2006, STALLERGENES recorded a turnover of 126.5 million euros, half of which on markets ... in North America. The 48-staff company expects a turnover of over EUR3.3 million in 2007 (of which 50% at ...

SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS

... of consumer trends. Every year, it invests around 10% of its turnover in R&D, reflecting its continued desire to understand, share and sublimate the best that nature has to offer. The annual turnover for Firmenich was 2.847 million Swiss francs at end-June 2008. ...

Pierre Fabre Dermatologie Starts Clinical Trials on a Beta-Blocker to Treat Severe Infantile Haemangioma

... France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. It employs nearly 10,000 people including ... drugs. In 2008, Pierre Fabre Medicament dedicated 33% of its annual turnover to R&D in five main therapeutic areas: oncology (priority sector with ...

Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.

... of 430 employees in Switzerland and Ireland, reports an expected 2008 turnover of over 279.5 million CHF, covering 75 countries worldwide, with over 20% of this turnover invested in R&D. Contact: Dr. Riccardo Braglia, CEO ...

Malaria: New Treatment is Upcoming

... sigma-tau was founded in Italy in 1957 and achieved a global turnover of EUR 665 million ($ 920 million) in 2007. sigma-tau SpA consistently invests 16% of its annual turnover in R&D. sigma-tau's 400 R&D staff are currently running 43 R&D ...

SENOMYX AND FIRMENICH TO COLLABORATE ON COMMERCIALIZATION OF S2383, A NOVEL ENHANCER OF THE HIGH-INTENSITY SWEETENER SUCRALOSE

... understanding of consumer trends. Every year, it invests around 10% of its turnover in R&D, reflecting its continued desire to understand, share and sublimate the best that nature has to offer. The annual turnover for Firmenich was 2.847 million Swiss francs at end June 2008. ...

Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009

... in sublingual desensitization treatments, Stallergenes devotes 20% of its turnover in raw data to Research and Development and is actively involved in the ... class: sublingual desensitization tablets. In 2007, Stallergenes had a turnover of 147 million euros and provided desensitization treatments to more than ...

Stallergenes Inaugurates the Biggest Pharmaceutical Allergen Production Unit in the World

... desensitisation treatments, Stallergenes devotes 20% in raw data of its turnover to Research and Development and is actively involved in the development of ... class: sublingual desensitisation tablets. In 2007, Stallergenes had a turnover of 147 million euros and provided desensitisation treatments to more than ...

Fufeng Announces 2008 Interim Results With Strong Sign of Recovery

... turnover Increased by 45.7% Profit Attributable to Shareholders Increased ... increased sales volume and selling price of major products, the Group's turnover increased to RMB1,630.4 million, representing an increase of 45.7%. The ...

Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth

... in sublingual desensitisation treatment, Stallergenes devotes 16% of its turnover to Research and Development and is actively involved in the development of ... class: sublingual desensitisation tablets. In 2007, Stallergenes had a turnover of 147 million euros and provided desensitisation treatments to more than ...

Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany

... in sublingual desensitisation treatments, Stallergenes devotes 18% of its turnover to Research and Development and is actively involved in the development of ... class: sublingual desensitisation tablets. In 2007, Stallergenes had a turnover of 147 million euros and provided desensitisation treatments to more than ...

Fufeng Announces 2007 Annual Results

... turnover Increased by 37% HONG KONG, April 22 /Xinhua-PRNewswire/ -- Fufeng Group ... year, driven by the increased sales volume of major products, the Group's turnover increased to RMB2,445.7 million, representing an increase of 37% compared ...

K-State's Subbaratnam Muthukrishnan and Barbara Valent Named Fellows of the American Association for the Advancement of Science

... the organization and functions of genes involved in the synthesis and turnover of the chitin in the exoskeleton of the red flour beetle. Muthukrishnan ... research team that identified several enzymes involved in the synthesis, turnover and hardening of a beetle's exoskeleton. The discovery could not only lead ...

Business Opportunities in Spain's Fast-Growing Biotechnology Industry

... The biotechnology sector is one of the most dynamic in Spain. It has maintained an annual growth rate for turnover and job creation of 30% according to data from ASEBIO, the Spanish Association of Bio-companies. Spain attracts international projects and financing ...

PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C.F.M. Group

... . Now in its 16th year PharmaVentures is based in Oxford, UK, employs over 50 people mostly educated to PhD or above, and has increased its turnover five fold with 80% of revenues from outside the UK. With offices in the USA and Australia, the Company works for a variety of clients from start-ups ...

Next Stage Solutions Announces Three New Financial Services For Emerging Business

... businesses hire a CFO who is not the right fit. The cost of these mistakes is staggering, both in dollars and efficiency: the average rate of CFO turnover at small and midsized companies is merely 20 months; the cost of screening and hiring two CFOs in a 20 month span can reach as high as $800,000, not ...

Nature parks can save species as climate changes

... adapt to climate change in the 21st century." The findings show that the biodiversity of particular areas is likely to change significantly. The turnover of species in some sites could be as high as 50 per cent, as established species leave to find more suitable climes or new food supplies, and new ...

New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the World's Leading Bioenergetics Researchers

... is the understanding of how the function of mitochondria within living cells is regulated to give the exquisite control of nutrient use and energy turnover that is characteristic of healthy cells. This leads naturally into study of the efficiency, of how its regulation and its effects on cells and ...

Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management

... in the US and Europe. It is predicted that more than 300 million patients will have this disease by 2025 (IDF). The market is about EUR bn9.6 turnover in 2007, expected to reach EUR bn15 by 2016. Existing therapies on the market are dominated by few dominant product classes, but significant ...

Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009

... flagship drug, with business agents who distribute the Company's products in 30 provinces and key major cities throughout China. Total turnover is projected to be more than RMB 105 million (US $15.3 million), of which 70 percent will be Sinobiopharma profit. Sales, ...

Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union

... 20 French or Portuguese speaking African countries. Bial is strongly committed to therapeutic innovation investing approximately 20% of its turnover in research and development every year. Key research areas for BIAL are the central nervous system, the cardiovascular system and allergology. Bial ...

Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign

... miserably and repeatedly. In an era where stalwart companies such as General Motors, Citigroup and Lehman Brothers have had high-level management turnover due to the failure of their respective management teams, in our opinion, there is absolutely no reason why Icagen should not follow suit. ...

Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS*

... and is actively involved in the development of a new therapeutic class: sublingual desensitization tablets. In 2008, Stallergenes had a turnover of 171 million euros and more than 500,000 patients were treated with Stallergenes desensitization products. Stallergenes is listed on ...

Mindray Announces 2008 Fourth Quarter and Full Year Results

... Data Average accounts receivable days outstanding was 40 days for the full year 2008 compared to 26 days for the full year 2007. Inventory turnover was 60 days for the full year 2008 compared to 55 days for the full year 2007. Average accounts payable days outstanding was 46 days for the full ...

Chronic Lung Disease - Axentis Pharma Attracts Investment Interest

... in the best light to powerful investors. Our lead product ARB-CF0223 - also known as Fluidosome(R) tobramycin - is expected to generate a peak annual turnover of approx. 100 million EUR within five years of market launch. The investment that we will be seeking in early 2010 will see us through until this ...

Cosun and Avantium Announce Collaboration

... ago. The cooperative currently has approximately 11,000 member/shareholders. Cosun has grown into a group with an average workforce of 4,300 and a turnover of some EUR 1.7 billion. For more information about Cosun Please visit the website: http://www.cosun.com About Avantium ...

Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project

... the Capital Region of Denmark. RAP delivers pharmacy services under GMP regulations to 14 hospitals serving 2,300 wards [nurse stations]. The yearly turnover is EUR200 million, and the 460-staff includes 75 pharmacists and 230 technicians. RAP supports three centers for cancer treatment and prepares ...

New uses for imidazolium salts in medicine and alternative energy

... gallate (EGCG), a green tea extract, have been known to slow down or prevent the oxidative process, they also exhibit low potencies and a rapid turnover in the body's metabolism. IBN Principal Research Scientist Lang Zhuo, Ph.D., said, "Our investigations with hepatic stellate cells show that IMSs ...

Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services

... According to Evan Siegel, "The addition of high quality technical Team Members, with an average of more than 20 years' experience, combined with zero turnover of our people, allow us to continue the excellent service we have always provided our clients. We continue to benefit from their loyalty, referrals, ...

ACIST Medical Systems Announces the Opening of Its New Expanded Corporate Headquarters in Eden Prairie, MN

... About the Bracco Group ACIST is part of the Bracco Group, founded in 1927 and today a worldwide integrated Healthcare Group, with annual turnover of more than 900 million Euro -- around 60% of which is from foreign sales. Bracco is present in approx. 80 countries both directly and through ...

Mindray Medical International Announces Second Quarter 2008 Results

... outstanding was 32 days for the second quarter 2008 compared to 21 days for the second quarter 2007 and 32 days for the first quarter 2008. Inventory turnover was 57 days for the second quarter 2008 compared to 59 days for the second quarter 2007 and 64 days for the first quarter 2008. Average accounts ...

SEKAB Agreement: More Verified Ethanol to Europe

... development of technology and production processes for ethanol from cellulose, with a second generation bio-ethanol pilot plant operating since 2004. turnover for 2007 amounted to 2 billion SEK. Head office and pilot plant are in Ornskoldsvik, Sweden. Contact Anders Fredriksson, EVP, SEKAB BioFuels ...

Quintiles Named to Computerworld Magazine's '100 Best Places to Work in Information Technology' List

... annual report takes into consideration average salary and bonus increases, the percentage of IT employees receiving promotions, IT staff turnover rates, training and development opportunities and the percentage of women and minorities in IT staff and management positions for US-based ...

Scientists fix bugs in our understanding of evolution

... insights into the evolution of DNA and protein sequences. The results challenge our understanding of how evolution happens and suggest that sequence turnover is much more common than assumed. "Evolution is happening so slowly that we cannot study it by simply watching it. That's why we learn about the ...

ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China

... since its founding in 1983. Octapharma owns five modern, state-of-the-art production facilities in Austria, France, Sweden, Mexico and Germany. Sales turnover in 2007 exceeded Euro 752 million. Octapharma continues to grow and invest heavily in the future. Profits are mainly channeled into R&D and further ...

220 Companies Place Switzerland First in Biotech Density Per Capita

... foreign investment agency Location Promotion Switzerland ( http://www.locationswitzerland.com ). "These firms employ 14,000 people and have an annual turnover of 7 billion Swiss francs," he says. "Supporting the industry are more than 300 research groups at universities and other public institutions ...

Mindray Medical International Announces First Quarter 2008 Results

... days outstanding was 32 days for the first quarter 2008 compared to 22 days for the first quarter 2007 and 26 days for the full year 2007. Inventory turnover was 64 days for the first quarter 2008 compared to 72 days for the first quarter 2007 and 55 days for the full year 2007. Average accounts payable ...

DxTech and Nicholas Piramal in POC Diagnostics Alliance

... by adhering to ethically sound, innovative and value-driven practices in its diverse, yet focused, business ventures and initiatives. The Group's turnover exceeded US$750 million in FY2007. The names of specific Group Companies are to be changed subject to shareholders' and Central Government's ....

Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research

... Class of Nonpeptidyl Small-Molecule Inhibitors of the Human Proteasome [Abstract # 3271] The ubiquitin-proteasome system (UPS) mediated protein turnover underlies many signaling pathways that are fundamental to cell proliferation, survival and death. Many important cellular proteins that are ...

Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge

... licences and 95 consultancy contracts were closed and the company assumed the management of a portfolio of 72 companies in which it holds equity. The turnover from technology and knowledge transfer was 6.0 million pounds of which 5.3 million pounds (88%) was returned to the University's academics and ...